PT813419E - Moduladores de proteinas reguladoras - Google Patents
Moduladores de proteinas reguladorasInfo
- Publication number
- PT813419E PT813419E PT96907886T PT96907886T PT813419E PT 813419 E PT813419 E PT 813419E PT 96907886 T PT96907886 T PT 96907886T PT 96907886 T PT96907886 T PT 96907886T PT 813419 E PT813419 E PT 813419E
- Authority
- PT
- Portugal
- Prior art keywords
- regulatory
- death domain
- modulator
- modulators
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Control Of Eletrric Generators (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL112742A IL112742A (en) | 1995-02-22 | 1995-02-22 | Antibodies to regulatory proteins |
IL11528995A IL115289A0 (en) | 1995-09-13 | 1995-09-13 | Modulators of regulatory proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
PT813419E true PT813419E (pt) | 2005-09-30 |
Family
ID=26322993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96907886T PT813419E (pt) | 1995-02-22 | 1996-02-15 | Moduladores de proteinas reguladoras |
Country Status (8)
Country | Link |
---|---|
EP (2) | EP1588712A1 (pt) |
JP (1) | JP3860608B2 (pt) |
AT (1) | ATE296107T1 (pt) |
CA (1) | CA2213484A1 (pt) |
DE (1) | DE69634774T2 (pt) |
ES (1) | ES2242195T3 (pt) |
PT (1) | PT813419E (pt) |
WO (1) | WO1996025941A1 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5712381A (en) * | 1994-10-19 | 1998-01-27 | Genetics Institute, Inc. | MADD, a TNF receptor death domain ligand protein |
US5849501A (en) * | 1994-10-19 | 1998-12-15 | Genetics Institute, Inc. | TNF receptor death domain ligand proteins and method to identify inhibitors of ligand binding |
US5852173A (en) * | 1994-10-19 | 1998-12-22 | Genetics Institute, Inc. | TNF receptor death ligand proteins and inhibitors of ligand binding |
US5847099A (en) * | 1994-10-19 | 1998-12-08 | Genetics Institute, Inc. | TNF receptor death domain ligand proteins |
IL114615A0 (en) | 1995-07-16 | 1995-11-27 | Yeda Res & Dev | Modulators of the function of fas receptors and other proteins |
US6399327B1 (en) | 1995-07-16 | 2002-06-04 | Yeda Research And Development Co. Ltd. | Modulators of the function of FAS receptors and other proteins |
AU7457796A (en) * | 1995-10-23 | 1997-05-15 | Tularik Inc. | Rip: novel human protein involved in tumor necrosis factor signal transduction, and screening assays |
GB9608335D0 (en) * | 1996-04-23 | 1996-06-26 | Univ Kingston | Method of enhancing ngf-mediated neurite growth with low molecular weight analoues of p.75 ngfr 367-379 |
US5858990A (en) * | 1997-03-04 | 1999-01-12 | St. Elizabeth's Medical Center | Fas ligand compositions for treatment of proliferative disorders |
IL120485A0 (en) * | 1997-03-19 | 1997-07-13 | Yeda Res & Dev | Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
ES2181197T3 (es) | 1997-04-25 | 2003-02-16 | Wyeth Corp | Isoformas de mort1 neuronal. |
WO1999000499A1 (en) * | 1997-06-26 | 1999-01-07 | Chiron Corporation | Human fadd-interacting protein (fip) |
US6235872B1 (en) * | 1998-03-12 | 2001-05-22 | The Burnham Institute | Proapoptotic peptides dependence polypeptides and methods of use |
SG148025A1 (en) * | 1998-03-19 | 2008-12-31 | Yeda Res & Dev | Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
IL126024A0 (en) * | 1998-03-19 | 1999-05-09 | Yeda Res & Dev | Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
US7745579B1 (en) | 1998-09-01 | 2010-06-29 | David Wallach | Inhibitor of NF-KB activation |
IL137524A0 (en) * | 2000-07-26 | 2001-07-24 | Yeda Res & Dev | A mort-1 interacting protein, its preparation and use |
AU2003215077A1 (en) * | 2002-02-11 | 2003-09-04 | Wyeth | Solution structure of rip dd and uses therof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL101769A (en) * | 1992-05-03 | 2007-02-11 | Yeda Res & Dev | Modulation of TNF receptor action |
IL111125A0 (en) * | 1994-05-11 | 1994-12-29 | Yeda Res & Dev | Soluble oligomeric tnf/ngf super family ligand receptors and their use |
ATE377073T1 (de) * | 1994-12-15 | 2007-11-15 | Yeda Res & Dev | Modulatoren der funktion des fas/ap01 rezeptors |
-
1996
- 1996-02-15 AT AT96907886T patent/ATE296107T1/de not_active IP Right Cessation
- 1996-02-15 PT PT96907886T patent/PT813419E/pt unknown
- 1996-02-15 EP EP05006413A patent/EP1588712A1/en not_active Withdrawn
- 1996-02-15 WO PCT/US1996/002326 patent/WO1996025941A1/en active IP Right Grant
- 1996-02-15 ES ES96907886T patent/ES2242195T3/es not_active Expired - Lifetime
- 1996-02-15 JP JP52579196A patent/JP3860608B2/ja not_active Expired - Fee Related
- 1996-02-15 DE DE69634774T patent/DE69634774T2/de not_active Expired - Fee Related
- 1996-02-15 EP EP96907886A patent/EP0813419B8/en not_active Expired - Lifetime
- 1996-02-15 CA CA002213484A patent/CA2213484A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ATE296107T1 (de) | 2005-06-15 |
EP0813419B1 (en) | 2005-05-25 |
DE69634774T2 (de) | 2006-02-02 |
JPH11500622A (ja) | 1999-01-19 |
EP1588712A1 (en) | 2005-10-26 |
EP0813419A4 (en) | 1999-07-14 |
EP0813419B8 (en) | 2005-08-24 |
EP0813419A1 (en) | 1997-12-29 |
JP3860608B2 (ja) | 2006-12-20 |
DE69634774D1 (de) | 2005-06-30 |
ES2242195T3 (es) | 2005-11-01 |
WO1996025941A1 (en) | 1996-08-29 |
CA2213484A1 (en) | 1996-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT813419E (pt) | Moduladores de proteinas reguladoras | |
ATE87811T1 (de) | Satz zur herstellung und abscheidung von endothelzellen. | |
EP0523140A4 (en) | Reagents and methods for modulating gene expression through rna mimicry | |
DE69727332D1 (de) | Zubereitungen enthaltend Kollagen, Vitamin D3 und Kalzium zur Verstärkung des Knochens | |
DE68918142D1 (de) | Zusammensetzungen und Verfahren zur kontrollierten Freisetzung von Duftstoffen. | |
DE68907553D1 (de) | Make-up-mittel zur menschlichen anwendung. | |
DE3878685D1 (de) | Implantat zur fixierung von wirbeln. | |
DE68909179D1 (de) | Verschlusselement zur Kontrolle von Ileokolostomie. | |
FR2703587B1 (fr) | Composition cosmetique coloree. | |
DE69308673D1 (de) | Lösung zur Verwendung bei der Transplantation von Organen | |
ATE180409T1 (de) | Kollagenzubereitung zur gesteuerten abgabe von wirkstoffen | |
DE69023608D1 (de) | Elektro-optischer Modulator. | |
AU527332B2 (en) | Bone connective prosthesis | |
AU3006789A (en) | Expression of hiv binding proteins | |
FR2626780B1 (fr) | Poupee simulant la poussee des cheveux | |
AU3335089A (en) | Economy chrome tanning | |
ATE302215T1 (de) | Modulatoren von intrazellulären entzündungs-, zelltod- und zellüberlebenswegen, die card- und kinase-domänen enthalten | |
NO922619D0 (no) | Blanding for kosmetisk stoff, spesielt for deodorantstift | |
DE58907554D1 (de) | Phenoxyalkylsubstituierte Heteroaromaten, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung von Schädlingen. | |
DE69323299D1 (de) | Treibmittelzusammensetzung, herstellung von schaumstoff mittels dieser zusammensetzung und daraus hergestellte schaumstoffe | |
AU8227998A (en) | Peptides containing the motif igd and their use as cell migration modulators | |
DE58903415D1 (de) | Mikromanipulator zur bewegung von objekten. | |
AU2900789A (en) | Electrooptic modulator | |
DD280029A1 (de) | Mittel zur erhoehung der stresstoleranz von kulturpflanzen | |
FI940822A0 (fi) | Foerfarande foer mikrobiologisk rening av material, som innehaoller skadliga aemnen |